Julianne Bruno - Jun 20, 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Chief Operating Officer
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
Stock symbol
CRSP
Transactions as of
Jun 20, 2024
Transactions value $
-$188,799
Form type
4
Date filed
6/24/2024, 05:35 PM
Previous filing
May 23, 2024
Next filing
Oct 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRSP Common Shares Options Exercise +7K +225.01% 10.1K Jun 20, 2024 Direct F1
transaction CRSP Common Shares Sale -$189K -3.37K -33.29% $56.09 6.75K Jun 21, 2024 Direct F2
holding CRSP Common Shares 7.09K Jun 20, 2024 The Julianne Bruno 2022 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Restricted Stock Units Options Exercise -7K -100% 0 Jun 20, 2024 Common Shares 7K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F2 Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
F3 This restricted stock unit award was granted on December 14, 2021 with respect to 7,000 Common Shares, with 100% of the shares vesting on June 20, 2024.